Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study.

Shieh Y, Heise RS, Madlensky L, Sabacan LP, Soto IA, Fiscalini AS, Ross K, Goodman D, Blanco A, Brain S, Heditsian DM, Moya J, Fergus KB, Olopade OI, Scheuner MT, Eklund M, Ziv E, Tice JA, van 't Veer L, Esserman LJ, Athena Breast Health Network and WISDOM Study Investigators and Advocate Partners

Open source

DOI: 10.1001/jamaoncol.2026.2091
Published: 2026 Aug 1
Container: JAMA oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamaoncol.2026.2091,
  title = {Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study.},
  author = {Shieh Y and Heise RS and Madlensky L and Sabacan LP and Soto IA and Fiscalini AS and Ross K and Goodman D and Blanco A and Brain S and Heditsian DM and Moya J and Fergus KB and Olopade OI and Scheuner MT and Eklund M and Ziv E and Tice JA and van 't Veer L and Esserman LJ and Athena Breast Health Network and WISDOM Study Investigators and Advocate Partners},
  year = {2026},
  journal = {JAMA oncology},
  doi = {10.1001/jamaoncol.2026.2091},
  url = {https://doi.org/10.1001/jamaoncol.2026.2091}
}

RIS

TY  - JOUR
TI  - Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study.
AU  - Shieh Y
AU  - Heise RS
AU  - Madlensky L
AU  - Sabacan LP
AU  - Soto IA
AU  - Fiscalini AS
AU  - Ross K
AU  - Goodman D
AU  - Blanco A
AU  - Brain S
AU  - Heditsian DM
AU  - Moya J
AU  - Fergus KB
AU  - Olopade OI
AU  - Scheuner MT
AU  - Eklund M
AU  - Ziv E
AU  - Tice JA
AU  - van 't Veer L
AU  - Esserman LJ
AU  - Athena Breast Health Network and WISDOM Study Investigators and Advocate Partners
PY  - 2026
JO  - JAMA oncology
DO  - 10.1001/jamaoncol.2026.2091
UR  - https://doi.org/10.1001/jamaoncol.2026.2091
ER  -

APA

Y, S., RS, H., L, M., LP, S., IA, S., AS, F., K, R., D, G., A, B., S, B., DM, H., J, M., KB, F., OI, O., MT, S., M, E., E, Z., JA, T., L, V. '. V., LJ, E., & Partners, A. B. H. N. A. W. S. I. A. A. (2026). Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study.. JAMA oncology. https://doi.org/10.1001/jamaoncol.2026.2091

Source records

pubmed · retrieved 2026-09-26T07:53:00.635Z